[go: up one dir, main page]

TNSN05082A1 - PYRAZOLE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR (TGF) - Google Patents

PYRAZOLE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR (TGF)

Info

Publication number
TNSN05082A1
TNSN05082A1 TNP2005000082A TNSN05082A TNSN05082A1 TN SN05082 A1 TNSN05082 A1 TN SN05082A1 TN P2005000082 A TNP2005000082 A TN P2005000082A TN SN05082 A TNSN05082 A TN SN05082A TN SN05082 A1 TNSN05082 A1 TN SN05082A1
Authority
TN
Tunisia
Prior art keywords
tgf
growth factor
transforming growth
pyrazole derivatives
inhibitors
Prior art date
Application number
TNP2005000082A
Other languages
French (fr)
Inventor
Laura Cook Blumberg
Michael John Munchhof
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/003933 external-priority patent/WO2004026306A2/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN05082A1 publication Critical patent/TNSN05082A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Des dérivés de pyrazole nouveaux de formule (Ia), Des intermédiaires pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation en médecine sont décrits. Les composés de la présente invention sont de puissants inhibiteurs de la voie de transmission de signal du facteur de croissance transformant ("TGF")- beta . Ils sont utiles dans le traitement de divers états pathologiques en rapport avec le TGF, comprenant, par exemple, le cancer et des maladies fibrotiques.Novel pyrazole derivatives of formula (Ia), intermediates for their preparation, pharmaceutical compositions containing them and their use in medicine are described. The compounds of the present invention are potent inhibitors of the transforming growth factor ("TGF") - beta signaling pathway. They are useful in the treatment of various disease states related to TGF, including, for example, cancer and fibrotic diseases.

TNP2005000082A 2002-09-18 2005-03-18 PYRAZOLE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR (TGF) TNSN05082A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41214602P 2002-09-18 2002-09-18
PCT/IB2003/003933 WO2004026306A2 (en) 2002-09-18 2003-09-08 Pyrazole derivatives as transforming growth factor (tgf) inhibitors

Publications (1)

Publication Number Publication Date
TNSN05082A1 true TNSN05082A1 (en) 2007-05-14

Family

ID=47043989

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000082A TNSN05082A1 (en) 2002-09-18 2005-03-18 PYRAZOLE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR (TGF)

Country Status (2)

Country Link
GT (1) GT200300203A (en)
TN (1) TNSN05082A1 (en)

Also Published As

Publication number Publication date
GT200300203A (en) 2004-06-23

Similar Documents

Publication Publication Date Title
MA27440A1 (en) PYRAZOLE DERIVATIVES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
MA27444A1 (en) NOVEL ISOTHIAZOLE AND ISOXAZOLE DERIVATIVES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
MA27442A1 (en) TRIAZOLE DERIVATIVES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
MA27443A1 (en) NOVEL OXAZOLES AND THIAZOLES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
ATE402929T1 (en) PYRAZINE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS
JP6258266B2 (en) Methods and compositions for treating disorders
CA2498047A1 (en) Novel imidazole compounds as transforming growth factor (tgf) inhibitors
MA27093A1 (en) SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
TW200504069A (en) Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors
MA27668A1 (en) 2,4-DI (PHENYLAMINO) PYRIMIDINES USED TO TREAT NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
FR2435471A1 (en) DIHYDROPYRIDINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
TNSN04156A1 (en) SUBSTITUTED PYRIDINONES AS MODULATORS OF MAP-KINASE P38
MA27867A1 (en) NOVEL 2H-PYRIDAZINE-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
MA29693B1 (en) XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
MA27144A1 (en) BENZAMIDE AND HETEROARYLAMIDE AS P2X7 RECEPTOR ANTAGONISTS
MA27448A1 (en) PYRIDINE DERIVATIVES MODULATORS OF THE CB2 RECEPTOR
TNSN07248A1 (en) PYRROLIDYL DERIVATIVE OF HETEROAROMATIC COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASES
MA28151A1 (en) BICYCLIC PYRAZOLYL AND IMIDAZOLYL DERIVATIVES AND USES THEREOF
WO1982001821A1 (en) Antimycotic synergistic pharmaceutical compositions and process for the preparation thereof
MA30539B1 (en) PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES INDUCED BY THE GPR38 RECEPTOR.
MA28742B1 (en) PYRIDO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC APPLICATION
MA28111A1 (en) DERIVATIVES
MA27661A1 (en) ANTIBACTERIAL INDOLONE-OXAZOLIDINONES, INTERMEDIARIES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA51558B1 (en) 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and similar compounds as c5a receptor modulators for the treatment of vascularity and inflammatory diseases
MA28429B1 (en) Derivatives of 1H-thieno [2,3-c] pyrazole useful as kinase inhibitors